Follow the people · Insider

BS

Brooke Story

Insider · Director · LIVN

Brooke Story files insider transactions with the SEC as a director of LivaNova (LIVN). We hold 1 disclosed purchase or sale filed since 16 June 2021, 1 of them in the last 90 days.

  • Files forLIVN
  • Disclosed buys and sells1 in all, 1 in the last 90 days
  • Last disclosure8 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 September 20224 September 2026Director · LivaNova (LIVN)19 Form 4 lines · source: SEC Form 4
  • Filed 15 July 202615 July 2026Director · PolyPid (PYPD)1 Form 4 line · source: SEC Form 4
  • Filed 14 June 202126 May 2022Director · Sigilon Therapeutics (SGTX)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

22 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.